Legal Opinion
In re Generic Digoxin & Doxycycline Antitrust Litigation
United States Judicial Panel on Multidistrict Litigation
Decided April 6, 2017No. MDL No. 2724PublishedCited by 7 opinions
1Opinion of the Court
TRANSFER ORDER
Sarah S. Vance, Chair
Before the Panel:* Plaintiff Rochester Drug Cooperative, Inc. (Rochester) moves under 28 U.S.C. § 1407(c) to transfer the ten actions listed on Schedule A to the Eastern District of Pennsylvania for inclusion in MDL No. 2724. Each of these ten actions involves antitrust claims brought by direct purchaser plaintiffs relating to one of six generic drugs: clobetasol, deso-nide, fluocinonide, econazole, levothyrox-ine, and propranolol. Rochester asks that the Panel expand the scope of MDL No. 2724 beyond generic digoxin and doxycy-cline to encompass these (and…
2Cases cited3 opinions
- In re Invokana (CANAGLIFLOZIN) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016
- In re Automotive Wire Harness Systems Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
- In re Capital One Telephone Consumer Protection Act LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
3Cited by7 opinions
- In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2018
- Cezana v. Robinhood Financial LLCDistrict Court, S.D. Florida · 2021
- Cheng v. Ally Financial Inc.District Court, S.D. Florida · 2021
- Dalton v. Robinhood Securities, LLCDistrict Court, S.D. Florida · 2021
- Days v. Robinhood Markets, Inc.District Court, S.D. Florida · 2021
2 more not listed; retrieve them via the Exa API.